Edaravone inhibits the disease activity in rheumatoid arthritis
- 1 April 2006
- journal article
- case report
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 31 (2) , 197-199
- https://doi.org/10.1111/j.1365-2710.2006.00722.x
Abstract
A male patient with rheumatoid arthritis (RA) developed acute stroke and was treated with the free radical scavenger, edaravone. Polyarthralgia improved with a reduction in serum C-reactive protein concentration soon after the start of edaravone administration. The disease activity score 28 (DAS28) also decreased. Edaravone appears to be effective for the control of RA. The usefulness of this potentially novel therapeutic agent should be tested in a well designed randomized controlled trial.Keywords
This publication has 14 references indexed in Scilit:
- Edaravone inhibits rheumatoid synovial cell proliferation and migrationFree Radical Research, 2006
- Edaravone Inhibits Acute Renal Injury and Cyst Formation in Cisplatin-Treated Rat KidneyFree Radical Research, 2004
- Clinical usefulness of edaravone for acute liver injuryJournal of Gastroenterology and Hepatology, 2003
- Protective effect of 3-methyl-1-phenyl-2-pyrazolin-5-one, a free radical scavenger, on acute toxicity of paraquat in miceToxicology Letters, 2003
- Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain InfarctionCerebrovascular Diseases, 2003
- Antioxidant Micronutrients and Risk of Rheumatoid Arthritis in a Cohort of Older WomenAmerican Journal of Epidemiology, 2003
- Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women:The American Journal of Medicine, 2002
- Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritisClinical Science, 2001
- Enhanced Mitochondrial Radical Production in Patients with Rheumatoid Arthritis Correlates with Elevated Levels of Tumor Necrosis Factor alpha in PlasmaFree Radical Research, 1996
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995